Cytori Therapeutics, Inc. (CYTX) Tops Q2 EPS by 1c

Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q2 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $2.46 million.

For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Mannatech (MTEX) Tops Q2 EPS by 53c
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c